Role of Myeloperoxidase as A Biomarker in Early Diagnosis of Sepsis in Pediatric Intensive Care Unit in Beni-Suef University Hospital

Abstract

Sepsis is a critical disorder that impacts numerous kids, regardless of existing health issues. Sepsis is considered one of the primary effects of mortality in kids, especially in developed nations. Sepsis is a life-threatening illness that impacts numerous children, regardless of existing health issues. Sepsis is considered one of the major reasons for mortality in kids, especially in developed nations. Despite demographic statistics not indicating it, numerous kids claimed to have died from other underlying diseases or died of sepsis directly. Systemic inflammatory response syndrome (SIRS) is a clinical condition resulting from inflammation, distinguished by tachypnea, fever, tachycardia, & leukocytosis. SIRS may result from a non-infectious inflammatory trigger or sepsis, such as polytrauma, surgical procedures, burns, or pancreatitis. It is essential to differentiate between sepsis & non-infectious systemic inflammatory response syndrome, as prompt antibiotic therapy is essential for sepsis survival. Myeloperoxidase (MPO) is a heme protein included within the azurophilic granules of neutrophils. Myeloperoxidase synthesizes hypochlorous a` & other reactive oxidants to phagocytoze ingested bacteria. Myeloperoxidase is a crucial element of innate immunity & a primary factor in the neutrophilic response to bacterial invasion. Neutrophils are the initial type of cell to respond in the host immunological response. Initiated neutrophils release their contents of granule, including myeloperoxidase, into the plasma. Myeloperoxidase may serve as a diagnostic biomarker to distinguish among SIRS without sepsis and infection.